Siemens Healthineers AG (SEMHF)
| Market Cap | 62.28B |
| Revenue (ttm) | 27.46B |
| Net Income (ttm) | 2.55B |
| Shares Out | n/a |
| EPS (ttm) | 2.27 |
| PE Ratio | 24.42 |
| Forward PE | 19.25 |
| Dividend | 0.99 (1.79%) |
| Ex-Dividend Date | Feb 19, 2025 |
| Volume | 507 |
| Average Volume | 1,686 |
| Open | 55.55 |
| Previous Close | 55.23 |
| Day's Range | 55.49 - 55.55 |
| 52-Week Range | 46.83 - 60.00 |
| Beta | 0.75 |
| RSI | 51.28 |
| Earnings Date | Nov 5, 2025 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial numbers in EUR Financial StatementsNews
Siemens evaluating spinoff of stake in Siemens Healthineers - report
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #drugtesting--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
Siemens Healthineers AG (SMMNY) Pre-Close For Q4 FY2025 (Transcript)
Siemens Healthineers AG - Special Call
Siemens Healthineers AG - Special Call Company Participants Presentation Unknown Executive Welcome to our pre-close catch-up for Q4 fiscal year 2025, which was recorded on September 25, 2025. In this ...
European Stocks Open Lower; H&M Surges, Siemens Healthineers (SHL) Falls
European Stocks Open Lower; H&M Surges, Siemens Healthineers (SHL) Falls
VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million
SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers...
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Deal Dispatch: White House Mute On TikTok, BBVA's $18 Billion Takeover Offer Rejected
New On The Block Siemens Healthineers is chatting with major private equity firms about a potential sale of its diagnostics business. According to Bloomberg, Blackstone , CVC , KKR , and Montagu are i...
EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen
Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward Collaboration combines AI imaging, diagnostics expertise, and clinical leadership t...
Carna Health and Siemens Healthineers join forces to Advance Kidney Care Innovation
BOSTON--(BUSINESS WIRE)--Carna Health, a digital health company revolutionizing kidney care, announced a strategic agreement with Siemens Healthineers to accelerate adoption of Carna's AI-enabled chro...
Siemens reduces stake in Siemens Healthineers to 71.12%
Siemens AG reduced its stake in medical technology company Siemens Healthineers by nearly 2 percentage points to 71.12%, according to a regulatory filing.
Siemens Healthineers AG 2025 Q3 - Results - Earnings Call Presentation
Siemens Healthineers AG (SEMHF) Q3 2025 Earnings Call Transcript
Siemens Healthineers reports Q3 results
'Trade barriers bad for the patients': Siemens Healthineers CEO
Siemens Healthineers CEO Bernd Montag warns EU-U.S. trade barriers are driving up healthcare costs, as company releases its Q2 earnings report.
Siemens Healthineers meets Q3 sales expectations, raises guidance
German medical technology company Siemens Healthineers on Wednesday reported third-quarter revenue slightly above analysts' consensus, citing strong growth in its China business after declines last ye...
Siemens Healthineers: More Upside Is Possible
Siemens Healthineers Sets New Sustainability Benchmark as First IVD Manufacturer to Earn My Green Lab ACT Ecolabel for Analyzers, Reagents
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #healthcaredistribution--Siemens Healthineers has earned My Green Lab ACT Ecolabel Certification for more than 150 reagents used by medical laboratories for patient ...
Siemens Healthineers does not expect China restrictions to affect business
Siemens Healthineers does not expect the current developments in China to have a material impact on its business, a spokesperson for the German medical technology group said on Monday.
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight
New York, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight The expansion of the preeclampsia diagnostics market is...
Healthineers: Reviewing Q2 And Updating My Targets (Rating Upgrade)
Siemens Healthineers reported strong Q2 '25 results, with 7% top-line growth and confirmed full-year outlook, despite challenges in China and tariffs. The company excels in imaging, holding a 37% mark...
Siemens Healthineers AG 2025 Q2 - Results - Earnings Call Presentation
Siemens Healthineers AG (SEMHF) Q2 2025 Earnings Call Transcript
Siemens Healthineers AG reports Q2 results
Siemens Healthineers Posts Profit, Revenue Rise; Adjusts Guidance on Tariff Uncertainty
The healthcare-equipment company posted a rise in net profit and revenue for its fiscal second quarter but widened its adjusted earnings per share range on increased tariff uncertainty.